$2.96
Sunshine Biopharma is conducting a public offering of units comprised of one share of common stock and one warrant exercisable for one share of common stock. The offering, however, is contingent upon the approval of the company's application for listing on the Nasdaq.
The company's stock currently trades on the Over-the-Counter Markets pink sheets under the ticker symbol "SBFM." If its application is approved, it will trade on the Nasdaq under the same ticker symbol.
What's in this guide?
Our top picks for where to buy Sunshine Biopharma stock
- Trade options, futures, options on futures, stocks, ETFs
- $0 commission to close options
- Pro-grade platform and risk analysis tools
- Trade $0 commission stocks & ETFs with as little as $1
- Theme and ETF screener
- Discover new opportunities with Opto's AI-driven classification system
- Trade stocks, options, ETFs, mutual funds, alternative asset funds
- $0 commission on stocks, ETFs and options, with no options contract fees
- Complimentary access to a financial planner and automated investing
How to buy Sunshine Biopharma stock
- Choose a stock trading platform. Use our comparison table
- Open an account. Provide your personal information and sign up.
- Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
- Search for the stock name – SBFM. Search for the stock by name or ticker symbol.
- Buy the stock. Place your order. It's that simple.
Buy Sunshine Biopharma stock from these online trading platforms
Compare special offers, low fees and a wide range of investment options among top trading platforms.Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Sunshine Biopharma stock price (NASDAQ: SBFM)
Use our graph to track the performance of SBFM stocks over time.Sunshine Biopharma shares at a glance
Latest market close | $3.06 |
---|---|
52-week range | $2.42 - $659.60 |
50-day moving average | $2.99 |
200-day moving average | $108.91 |
Wall St. target price | $300.00 |
PE ratio | N/A |
Dividend yield | N/A |
Earnings per share (TTM) | $-378.25 |
Is it a good time to buy Sunshine Biopharma stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Sunshine Biopharma price performance over time
Historical closes compared with the close of $3.01 from 2024-10-18
1 week (2024-10-15) | 2.03% |
---|---|
1 month (2024-09-20) | -4.75% |
3 months (2024-07-22) | 878.86% |
6 months (2024-04-22) | 109.03% |
1 year (2023-10-20) | 900.00% |
---|---|
2 years (2022-10-21) | 181.31% |
3 years (2021-10-22) | 18.5 |
5 years (2019-10-22) | 5.2 |
Sunshine Biopharma financials
Revenue TTM | $30.5 million |
---|---|
Gross profit TTM | $1.7 million |
Return on assets TTM | -9.91% |
Return on equity TTM | -15.79% |
Profit margin | -12.07% |
Book value | $20.06 |
Market Capitalization | $3.6 million |
TTM: trailing 12 months
Sunshine Biopharma share dividends
We're not expecting Sunshine Biopharma to pay a dividend over the next 12 months.
You may also wish to consider:
- Sanofi ADR (SNY.US) (3.71% forward annual dividend yield)
- Pfizer (PFE.US) (5.74% forward annual dividend yield)
Have Sunshine Biopharma's shares ever split?
Sunshine Biopharma's shares were split on a 1:20 basis on 7 August 2024 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Sunshine Biopharma shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Sunshine Biopharma shares which in turn could have impacted Sunshine Biopharma's share price.
Sunshine Biopharma share price volatility
Over the last 12 months, Sunshine Biopharma's shares have ranged in value from as little as $2.42 up to $659.6. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Sunshine Biopharma's is -1.102. This would suggest that Sunshine Biopharma's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Sunshine Biopharma has bucked the trend.
To put Sunshine Biopharma's beta into context you can compare it against those of similar companies.
- Sanofi ADR (SNY.US): 0.423
- Pfizer (PFE.US): 0.617
- Moderna (MRNA.US): 1.661
Sunshine Biopharma overview
Sunshine Biopharma, Inc. , a pharmaceutical company, focuses on the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. It operates in two segments, Prescription Generic Pharmaceuticals and Nonprescription Over-The-Counter Products. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; Adva-27a, a small chemotherapy molecule to treat pancreatic cancer; and K1. 1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, and anticonvulsant indications.
Frequently asked questions
What percentage of Sunshine Biopharma is owned by insiders or institutions?Currently 0.415% of Sunshine Biopharma shares are held by insiders and 1.129% by institutions. How many people work for Sunshine Biopharma?
Latest data suggests 44 work at Sunshine Biopharma. When does the fiscal year end for Sunshine Biopharma?
Sunshine Biopharma's fiscal year ends in December. Where is Sunshine Biopharma based?
Sunshine Biopharma's address is: 333 Las Olas Way, Fort Lauderdale, FL, United States, 33301 What is Sunshine Biopharma's ISIN number?
Sunshine Biopharma's international securities identification number is: US8677814035
More guides on Finder
-
Fundamental Analysis
Fundamental analysis of stocks can help you become a better investor and find the true value of stocks and other assets.
-
Best Stocks for Beginners With Little Money to Invest
These are the stocks to buy when you don’t have much to spend.
-
7 Best Day Trading Apps of 2024
These are the best day trading apps, according to Finder’s comprehensive analysis.
-
Today’s Best Brokerage Account Bonuses [Signup and Transfer Promos]
Explore the best bonuses for opening a new brokerage account.
-
eToro review 2024: Commission-free social trading and investing
eToro is a robust trading platform with an easy-to-use interface and no commissions on stocks and ETFs.
-
Titan Review 2024: Wealth Management With a No-Advisory-Fee Robo-Advisor
Titan invest is a members-only automated platform best for hands-off investors looking to build wealth.
-
Public.com Review 2024: No-Fee Options, With Rebates
A beginner-friendly investing platform with fractional shares and no commissions on stocks and ETFs.
-
How to invest in the S&P 500 in 2024
What you need to know about investing in the leading indicator for the overall US stock market.
-
Wealthfront review: Low-cost automated and DIY investing
Learn about Wealthfront’s automated investing tools and services to see if it’s the right platform for you.
-
How to trade options
Read our beginner’s guide to trading options in the US.
Ask a question